4.8 Article

G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0905778107

Keywords

cyclin-dependent kinase 2; G2/M checkpoint; Pin1; degradation; p53

Funding

  1. Ministerio de Educacion y Ciencia [SAF2008-00552]
  2. Fundacion Mutua Madrilena
  3. Fundacion Ramon Areces
  4. Cardiovascular Network of Ministerio Sanidad y Consumo-Instituto Carlos III [RD06-0014/0037]
  5. Comunidad de Madrid [S-SAL-0159-2006]
  6. MAIN European Network [LSHG-CT-2003-502935]
  7. Comunidad de Madrid and Universidad Autonoma de Madrid [CCG08-UAM/BIO-4452]
  8. Ramon y Cajal

Ask authors/readers for more resources

Cell cycle progression requires changes in the activity or levels of a variety of key signaling proteins. G protein-coupled receptor kinase 2 (GRK2) plays a central role in G protein-coupled receptor regulation. Recent research is uncovering its involvement in additional cellular functions, but the potential role of GRK2 in the cell cycle has not been addressed. We report that GRK2 protein levels are transiently down-regulated during the G2/M transition by a mechanism involving CDK2-mediated phosphorylation of GRK2 at Serine670, which triggers binding to the prolyl-isomerase Pin1 and subsequent degradation. Prevention of GRK2 phosphorylation at S670 impedes normal GRK2 down-regulation and markedly delays cell cycle progression. Interestingly, we find that endogenous GRK2 down-regulation is prevented on activation of the G2/M checkpoint by doxorubicin and that stabilized GRK2 levels in such conditions inversely correlate with the p53 response and the induction of apoptosis, suggesting that GRK2 participates in the regulatory network controlling cell cycle arrest and survival in such conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2

David Aluja, Javier Inserte, Petronila Penela, Paula Ramos, Catalina Ribas, Miguel Angel Iniguez, Federico Mayor, David Garcia-Dorado

BASIC RESEARCH IN CARDIOLOGY (2019)

Review Biochemistry & Molecular Biology

G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub

Petronila Penela, Catalina Ribas, Francisco Sanchez-Madrid, Federico Mayor

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Article Medicine, General & Internal

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

Petronila Penela, Javier Inserte, Paula Ramos, Antonio Rodriguez-Sinovas, David Garcia-Dorado, Federico Mayor

EBIOMEDICINE (2019)

Article Oncology

GRK2-Dependent HuR Phosphorylation Regulates HIF1α Activation under Hypoxia or Adrenergic Stress

Clara Reglero, Vanesa Lafarga, Veronica Rivas, Angela Albitre, Paula Ramos, Susana R. Berciano, Olga Tapia, Maria L. Martinez-Chantar, Federico Mayor, Petronila Penela

CANCERS (2020)

Article Biochemistry & Molecular Biology

Myeloid GRK2 Regulates Obesity-Induced Endothelial Dysfunction by Modulating Inflammatory Responses in Perivascular Adipose Tissue

Maria Gonzalez-Amor, Rocio Vila-Bedmar, Raquel Rodrigues-Diez, Rosa Moreno-Carriles, Alba C. Arcones, Marta Cruces-Sande, Mercedes Salaices, Federico Mayor, Ana M. Briones, Cristina Murga

ANTIOXIDANTS (2020)

Article Cell Biology

Cardiac GRK2 Protein Levels Show Sexual Dimorphism during Aging and Are Regulated by Ovarian Hormones

Alba C. Arcones, Melanie Raquel Martinez-Cignoni, Rocio Vila-Bedmar, Claudia Yanez, Isabel Llado, Ana M. Proenza, Federico Mayor, Cristina Murga

Summary: A clear sexual dimorphism in cardiovascular disease (CVD) risk is observed, with young women having a lower incidence compared to age-matched men, but this protection is lost after menopause. Changes in G protein-coupled receptor kinase 2 (GRK2) protein levels in the heart are linked to age-related sensitivity to CVD development, with ovarian hormones playing a role in regulating GRK2 levels in the cardiac muscle, contributing to the sex-dependent dynamics of CVD risk.

CELLS (2021)

Article Cell Biology

Mdm2-Mediated Downmodulation of GRK2 Restricts Centrosome Separation for Proper Chromosome Congression

Clara Reglero, Belen Ortiz del Castillo, Veronica Rivas, Federico Mayor Jr, Petronila Penela

Summary: This study reveals that Mdm2 E3 ligase controls centrosome separation by degrading GRK2, ensuring accurate centrosome dynamics and proper mitotic spindle functionality.

CELLS (2021)

Article Biochemistry & Molecular Biology

Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells

Maria Neves, Viviana Marolda, Federico Mayor, Petronila Penela

Summary: A better understanding of the crosstalk between key receptors and signaling pathways involved in cancer progression, specifically in breast cancer subtypes, is crucial for improving current therapies and addressing tumor microenvironment. This study examines the interplay between CXCR4/ACKR3 chemokine receptors and EGFR family signaling pathways in different breast cancer cell models and highlights their cooperation in promoting ERK1/2 activation, with potential implications for cancer progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Anais Jimenez-Reinoso, Nestor Tirado, Alba Martinez-Moreno, Victor M. Diaz, Marina Garcia-Peydro, Oana Hangiu, Laura Diez-Alonso, Angela Albitre, Petronila Penela, Maria L. Toribio, Pablo Menendez, Luis Alvarez-Vallina, Diego Sanchez Martinez

Summary: CD1a-STAb T cells could be an alternative to CD1a-CAR T cells for coT-ALL patients with aggressive and hyperleukocytic relapses and limited numbers of non-leukemic effector T cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Physiology

The stress connection in cancer: the adrenergic fuelling of breast tumors

Angela Albitre, Clara Reglero, Teresa Gonzalez-Munoz, Petronila Penela

Summary: Cancer progression involves complex interactions between tumor cells and the surrounding microenvironment. Chronic psychosocial stress and sympathetic nervous system activation lead to abnormal catecholamine release, impacting tumor cells directly and indirectly and fueling cancer-promoting effects. Understanding the interaction between adrenergic receptors and other signaling pathways is crucial for developing effective therapies targeting adrenergic-driven breast cancer progression.

CURRENT OPINION IN PHYSIOLOGY (2023)

Article Chemistry, Medicinal

Modulation of CXCR4-Mediated Gi1 Activation by EGF Receptor and GRK2

Maria Neves, Cristina Perpina-Viciano, Petronila Penela, Carsten Hoffmann, Federico Mayor

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

No Data Available